Qingdao Yingkang Medical Investment Co., Ltd. acquired Hangzhou Yikang Traditional Chinese Medicine Tumor Hospital Co., Ltd. from INKON Life Technology Co., Ltd. for CNY 1.3 million.
September 12, 2021
Share
Qingdao Yingkang Medical Investment Co., Ltd. agreed to acquire Hangzhou Yikang Traditional Chinese Medicine Tumor Hospital Co., Ltd. from INKON Life Technology Co., Ltd. (SZSE:300143) for CNY 1.3 million on August 6, 2021. The price of this equity transfer was based on the evaluation results and negotiated by both parties to the transaction. The price of the creditor’s rights transfer is the sum of the principal of the loan under the "Loan Contract" that the company has on Hangzhou Yikang (the upper limit of the loan is CNY 82 million. The specific amount is based on the actual loan amount as of the date of payment of the consideration for this transaction) and the corresponding amount of all the corresponding interest incurred according to the "Loan Contract" (calculated until the payment date of the creditor’s rights transfer consideration). As of August 30, 2021, INKON Life Technology Co., Ltd. shareholders approved the transaction in special shareholders’ meeting.
Qingdao Yingkang Medical Investment Co., Ltd. completed the acquisition of Hangzhou Yikang Traditional Chinese Medicine Tumor Hospital Co., Ltd. from INKON Life Technology Co., Ltd. (SZSE:300143) on September 10, 2021.
INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.
Qingdao Yingkang Medical Investment Co., Ltd. acquired Hangzhou Yikang Traditional Chinese Medicine Tumor Hospital Co., Ltd. from INKON Life Technology Co., Ltd. for CNY 1.3 million.